Pulmonary-Allergologic Area

Neopharmed Gentili’s commitment to the Pulmonary-Allergologic Area manifests in its dedication towards supporting individuals that have to deal with respiratory diseases, both allergic and non, on a daily basis, such as Chronic Obstructive Pulmonary disease, bronchial asthma, and rhinitis. 

Allergies are triggered by the immune system’s reaction to generally harmless substances like pollen, animal dander, or insect venom, which the body perceives as threats. COPD is a chronic disease that causes a persistent obstruction of the respiratory tract, impeding regular breathing. Bronchial asthma manifests with the narrowing of the lower respiratory tract, caused by inflammation that reduces the space air passes through to reach the lungs, rendering breathing more laborious.

Allergic rhinitis is an inflammatory condition that affects the upper respiratory tract, resulting in symptoms that include nasal congestion, sneezing, or itchiness, often tied to exposure to environmental allergens.

The various respiratory conditions, both allergic and non, compromise quality of life. A proper therapeutic approach allows for the management of immune system reactions and respiratory issues, thereby substantially alleviating symptoms and complications. This is one of the objectives that shape Neopharmed Gentili’s daily efforts.

HCP

Organized by therapeutic areas, in this section, accredited physicians can download all informational materials and specific updates related to each medicine distributed by Neopharmed Gentili.

READ ALL INFORMATION AND SERVICES

HISTORY

We are an Italian pharmaceutical company that has historically operated within national borders, and we are currently in the process of expanding internationally.

LEARN MORE